对高胆固醇血症新兴生物疗法的最新审查
1Faculty of Medicine, Macau University of Science & Technology, Macau, China.
Expert opinion on biological therapy
|December 13, 2024
概括
针对蛋白转化酶亚提利辛/凯类型9 (PCSK9),阿波利波蛋白C3 (apoC3) 和血管类型3 (ANGPTL3) 的新生物疗法对管理高胆固醇血症和降低心血管风险比他类药物更有前途.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 高胆固醇和脂质疾病是动脉样硬化心血管疾病 (ASCVD) 的主要驱动因素.
- 虽然他类药物有效,但往往无法达到目标低密度脂蛋白 (LDL) 胆固醇水平,留下残留的脂质危险因素.
- 需要新的治疗策略来解决当前降脂治疗方法的不足.
研究的目的:
- 审查新兴的高胆固醇血症的生物疗法.
- 为突出超越传统降脂剂的新药标.
- 评估新生物制剂在减少心血管事件方面的潜力.
主要方法:
- 在PubMed文献中搜索正在开发的高胆固醇血症的生物疗法.
- 对针对PCSK9,apoC3,ANGPTL3和脂蛋白的药物的审查 (a) [Lp (a) ].
- 对这些新型药物的有效性和潜在应用现有数据的分析.
主要成果:
- 抑制PCSK9仍然是一个关键的重点,新的单克隆抗体和腺素疗法显示出希望.
- 针对apoC3和ANGPTL3的反感性寡核酸 (ASO) 和小干扰RNA (siRNA) 对严重的高甘油三血症和同胞性家族性高胆固醇血症有效.
- 针对Lp(a) 的ASO和siRNA正在心血管结局研究中进行调查.
结论:
- 针对PCSK9,apoC3,ANGPTL3和Lp的生物疗法代表了管理高胆固醇血症的重大进展.
- 这些新型药物在降低心血管风险方面具有更广泛的应用潜力,特别是在残留风险的患者中.
- 进一步的临床研究至关重要,以确认这些有前途的治疗方法的长期疗效和安全性.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
532
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
532
01:29Cholesterol: Significance and Regulation
504
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
504
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
477
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
477
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120